ArticleFrontiers in pharmacology2024

Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy.

Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.